Startups
Somite.ai is developing AI foundation models for human stem cells to drive novel cell therapies at scale. We take a full-stack approach—generating data at 1,000x lower cost, training large-scale models with unmatched predictive power, and using these models to discover, refine, and optimize high-impact applications in cell therapy. Our founding team includes repeat AI entrepreneur Dr. Micha Breakstone (Chorus.ai, acquired for $575M), the Head of the Fundamental AI Group at MIT (pioneered the foundational research on scaling laws), and four Harvard Medical School professors and National Academy of Sciences/Medicine members, including the Chair of the Genetics Department at HMS. Based in Boston and launching operations in January 2024, Somite has raised over $11M in pre-seed funding
Overview
Location
United States
Total raised
$57.1M
Investors 3
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| TechAviv Founder Partners | techaviv.com | |
| Jul 13, 2025 | Chan Zuckerberg Initiative | chanzuckerberg.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Sep 9, 2024 | Pre-seed round | $4.8M | |
| Apr 16, 2024 | Pre-seed round | $5.3M |
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 18, 2025 | Somite AI: $47 Million Series A Raised To Accelerate Human Cell Therapy Development | Somite AI, a tech-bio company utilizing foundation models and proprietary AI to advance human cell therapy development, announced it closed a Series A funding round raising more than $47 million. The funding round was led by Khosla Ventures... |
| May 13, 2025 | Somite AI Grabs $47M Series A Funding | BOSTON, MA, Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, closed its Series A funding round, raising more than $47 million. >> Click here for more funding d... |
| May 13, 2025 | Somite AI Raises Series A Funding | Somite AI, a Boston, MA-based TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, raised an undisclosed amount in Series A funding. The round was led by Khosla Ventures, with partici... |
| May 13, 2025 | Somite AI Raises $47M Series A To Reinvent Cell Replacement Therapy | Startup Somite AI announced today that it has raised over $47 million in a Series A funding round, bringing its total funding to about $60 million. The round was led by Khosla Ventures, with participation from SciFi VC, the Chan Zuckerberg ... |
| Sep 9, 2024 | Somite Therapeutics Raises $4.8M Extension of Pre-Seed Funding | Somite Therapeutics, a Boston, MA-based TechBio company leveraging big data and AI to introduce novel cell replacement therapies, raised a $4.8M extension of its pre-seed funding. This round, which brought total funds raised to over $10M, w... |
| Sep 9, 2024 | Somite Therapeutics and OmniaBio Inc. Announce Collaboration to Advance Somite's Cell Therapy Flagship Program | CDMO collaboration propels cell replacement therapy targeting Duchenne muscular dystrophy forward, with consequences for the role of AI in cell therapy BOSTON and HAMILTON, Ontario, Sept. 9, 2024 /PRNewswire/ -- Somite Therapeutics, a tech-... |
| Sep 3, 2024 | Somite Therapeutics Announces Round Extension with Astellas Venture Management and Montage Ventures Joining as Board Observers | To comply with academic institution guidelines, the founders' academic affiliations and roles are listed only at the end of the statement. BOSTON, Sept. 3, 2024 /PRNewswire/ -- Somite Therapeutics, a fully integrated TechBio company leverag... |
| Sep 3, 2024 | Somite Inks $4.8M Pre-Seed Extension Round | BOSTON, MA, Somite Therapeutics today announced a $4.8 million extension of its pre-seed round. >> Click here for more funding data on Somite >> To export Somite funding data to PDF and Excel, click here Somite Therapeutics, a ... |
| May 21, 2024 | Prof. Jay Shendure Joins Somite Therapeutics as Scientific Co-founder | [[To comply with academic institution guidelines, the founders' academic affiliations and roles are listed only at the end of the statement.]] BOSTON, May 21, 2024 /PRNewswire/ -- Somite Therapeutics, a tech-bio company harnessing big data ... |
Show more
Reviews 0
FAQ about Somite
How much funding has Somite raised?
Somite has raised $57.1M in total across 3 funding rounds.
What funding rounds has Somite raised?
Parsers VC lists 3 funding rounds of Somite, among them a pre-seed round of $4.8M on Sep 9, 2024 and a pre-seed round of $5.3M on Apr 16, 2024.
Who has invested in Somite?
Parsers VC lists 3 investors of Somite, among them Chan Zuckerberg Initiative and TechAviv Founder Partners.
What has the press written about Somite?
Parsers VC has collected 17 articles mentioning Somite, among them “Somite AI: $47 Million Series A Raised To Accelerate Human Cell Therapy Development” (May 18, 2025) and “Somite AI Grabs $47M Series A Funding” (May 13, 2025).
Is Somite still active?
Yes, Somite is active; its latest activity on Parsers VC dates from Jul 10, 2026.